E, R., JS, F., K, T., MC, R., CC, L., & D, A. (2019). CAR-T Engineering: Optimizing Signal Transduction and Effector Mechanisms. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 33(6), 647. https://doi.org/10.1007/s40259-019-00384-z
Chicago Style (17th ed.) CitationE, Roselli, Frieling JS, Thorner K, Ramello MC, Lynch CC, and Abate-Daga D. "CAR-T Engineering: Optimizing Signal Transduction and Effector Mechanisms." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 33, no. 6 (2019): 647. https://doi.org/10.1007/s40259-019-00384-z.
MLA (9th ed.) CitationE, Roselli, et al. "CAR-T Engineering: Optimizing Signal Transduction and Effector Mechanisms." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol. 33, no. 6, 2019, p. 647, https://doi.org/10.1007/s40259-019-00384-z.